Novo Nordisk is acquiring Akero Therapeutics for drug candidate efruxifermin, which executive say could be first and best in the emerging class of FGF21 analogs for the fatty liver disease MASH. The deal comes months after Novo’s internal FGF21 drug candidate failed a Phase 2 trial. The post With $4.7B Akero Acquisition, Novo Nordisk Maps…
Experts warn that the Trump administration’s new $100,000 fee for H-1B visa applications could worsen healthcare’s workforce crisis, especially in rural areas, by making it prohibitively expensive for hospitals to hire international clinicians. Critics are also worried that the change could slow the pace of healthcare innovation by discouraging foreign workers from contributing to the…
Devices can send information back to a physician, but that data doesn’t explain how the experience felt. Without that context, healthcare teams miss the very details that shape adherence, satisfaction, and long-term outcomes. The post Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home appeared first on MedCity News.
Devices can send information back to a physician, but that data doesn’t explain how the experience felt. Without that context, healthcare teams miss the very details that shape adherence, satisfaction, and long-term outcomes. The post Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home appeared first on MedCity News.
HealthTap is now offering virtual primary care for patients with diabetes on LillyDirect, becoming the platform’s first primary care provider. The post HealthTap Joins LillyDirect to Expand Access to Primary Care–Led Diabetes Treatment appeared first on MedCity News.
Nilo Therapeutics’ Series A round was led by The Column Group, DCVC Bio, and Lux Capital. The preclinical startup is developing drugs targeting neural circuits that control systemic inflammation. The post Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’ appeared first on MedCity News.
To meaningfully scale mental health care — and improve outcomes along the way — we must move beyond the rigid constraints of episodic care and toward a model that is continuous, intelligent, and adaptive to individual needs. The post Beyond the Session: A Smarter Mental Health Model appeared first on MedCity News.
The next era of health won’t be defined by how big our hospitals are. It will be defined by how fast – and how fairly – we deliver care. The post We’ve Taught Machines To Save Lives — Now We Need To Let Them appeared first on MedCity News.
Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…
Mental health company Talkspace has purchased Wisdo Health, an AI-powered platform for social health and peer support. The post Talkspace Acquires Peer Support Platform Wisdo Health appeared first on MedCity News.